These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39253841)

  • 1. Relation Between Characteristics of Indocyanine Green Lymphography and Development of Breast Cancer-Related Lymphedema.
    Thomis S; Ronsse S; Bechter-Hugl B; Fourneau I; Devoogdt N
    Lymphat Res Biol; 2024 Oct; 22(5):248-254. PubMed ID: 39253841
    [No Abstract]   [Full Text] [Related]  

  • 2. ICG lymphographic findings following immediate lymphatic reconstruction in breast cancer patients.
    Buchan G; Cakmakoglu C; Schwarz GS
    J Plast Reconstr Aesthet Surg; 2022 Jul; 75(7):2164-2171. PubMed ID: 35370119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema.
    Suami H; Heydon-White A; Mackie H; Czerniec S; Koelmeyer L; Boyages J
    BMC Cancer; 2019 Oct; 19(1):985. PubMed ID: 31640623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supermicrosurgery lymphaticovenous and lymphaticolymphatic anastomosis: Technical detail and short-term follow-up for immediate lymphatic reconstruction in breast cancer treatment-related lymphedema prevention.
    Brahma B; Yamamoto T; Panigoro SS; Haryono SJ; Yusuf PA; Priambodo PS; Harimurti K; Taher A
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101863. PubMed ID: 38428499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate-delayed lymphatic reconstruction after axillary lymph nodes dissection for locally advanced breast cancer-related lymphedema prevention: Report of two cases.
    Brahma B; Yamamoto T; Agdelina C; Adella D; Putri RI; Hanifah W; Sundah VH; Perdana AB; Putra MRA; Taher A; Panigoro SS
    Microsurgery; 2024 Jan; 44(2):e31033. PubMed ID: 36896960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the Association Between Breast Cancer-Related Lymphedema and the Side Effects of Taxane-Based Chemotherapy Using Indocyanine Green Lymphography.
    Tokumoto H; Akita S; Nakamura R; Yamamoto N; Kubota Y; Mitsukawa N
    Lymphat Res Biol; 2022 Dec; 20(6):612-617. PubMed ID: 35099282
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing breast lymphoedema following breast cancer treatment using indocyanine green lymphography.
    Heydon-White A; Suami H; Boyages J; Koelmeyer L; Peebles KC
    Breast Cancer Res Treat; 2020 Jun; 181(3):635-644. PubMed ID: 32378054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
    Bhimani F; Feldman S; Cavalli A; Chen Y; Obaid L; Rachofsky C; Gupta A; Pastoriza J; Johnson K; McEvoy M
    Ann Surg Oncol; 2024 Sep; 31(9):5937-5946. PubMed ID: 38844631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions.
    Brahma B; Yamamoto T
    Eur J Surg Oncol; 2019 Jul; 45(7):1138-1145. PubMed ID: 30638810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: A systematic review.
    Abbaci M; Conversano A; De Leeuw F; Laplace-Builhé C; Mazouni C
    Eur J Surg Oncol; 2019 Oct; 45(10):1778-1786. PubMed ID: 31221460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of fluorescence lymphography for sentinel lymph node biopsy in breast cancer. Summary experience of several specialized centers].
    Bozhok AA; Zikiryakhodzhaev AD; Kvetenadze GE; Moshurova MV; Timoshkin VO; Shomova MV; Manelov AE
    Khirurgiia (Mosk); 2024; (10):49-61. PubMed ID: 39422006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging.
    Aldrich MB; Rasmussen JC; DeSnyder SM; Woodward WA; Chan W; Sevick-Muraca EM; Mittendorf EA; Smith BD; Stauder MC; Strom EA; Perkins GH; Hoffman KE; Mitchell MP; Barcenas CH; Isales LE; Shaitelman SF
    Breast Cancer Res Treat; 2022 Aug; 195(1):33-41. PubMed ID: 35816269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Detection of Breast Cancer-Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared with Bioimpedance Spectroscopy and Subclinical Lymphedema Symptoms.
    Soran A; Bengur FB; Rodriguez W; Chroneos MZ; Sezgin E
    Lymphat Res Biol; 2023 Aug; 21(4):359-365. PubMed ID: 36946918
    [No Abstract]   [Full Text] [Related]  

  • 17. Superficial and functional imaging of the tricipital lymphatic pathway: a modern reintroduction.
    Friedman R; Bustos VP; Pardo J; Tillotson E; Donohoe K; Chatterjee A; Ciucci JL; Singhal D
    Breast Cancer Res Treat; 2023 Jan; 197(1):235-242. PubMed ID: 36326995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of breast-cancer-related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two-arm randomized clinical trial.
    Gennaro M; Maccauro M; Mariani L; Listorti C; Sigari C; De Vivo A; Chisari M; Maugeri I; Lorenzoni A; Aliberti G; Scaperrotta GP; Caraceni A; Pruneri G; Folli S
    Cancer; 2022 Dec; 128(24):4185-4193. PubMed ID: 36259883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.
    Young S; Geary A; Zhao X; Kenzik K; Cassidy M; Newman R; Merrill AL
    J Surg Oncol; 2024 Aug; 130(2):204-209. PubMed ID: 38873777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.